Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Schweizerische Medizinische Wochenschrift
|
September 18, 1993
[Effect of inpatient treatment on pulmonary findings and subjective well-being of patients with chronic bronchitis]
S Büchi, C Buddeberg, C Wolf, et al.
The Journal of Biological Chemistry
|
June 10, 1981
Gelatin-binding domain-specific anti-human plasma fibronectin Fab' inhibits fibronectin-mediated gelatin binding but not cell spreading
J A McDonald, T J Broekelmann, D G Kelley, et al.
The American Review of Respiratory Disease
|
November 1, 1981
Bronchoalveolar fibronectin in smokers and nonsmokers
B Villiger, T Broekelmann, D Kelley, et al.
The European Respiratory Journal
|
June 1, 1997
Psychosocial predictors of long-term success of in-patient pulmonary rehabilitation of patients with COPD
S Büchi, B Villiger, T Sensky, et al.
Deutsche Medizinische Wochenschrift (1946)
|
March 20, 1998
[The importance of training intensity for improving endurance capacity of patients with chronic obstructive pulmonary disease]
J D Leuppi, R Zenhäusern, F Schwarz, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|
May 26, 1987
[Combination of anticholinergic, beta-2-sympathomimetic agents and theophylline in the treatment of chronic obstructive lung disease. A double-blind multicenter study of 60 patients]
R Bezel, O Brändli, P Braun, et al.
The Journal of Cell Biology
|
September 1, 1981
Human alveolar macrophage fibronectin: synthesis, secretion, and ultrastructural localization during gelatin-coated latex particle binding
B Villiger, D G Kelley, W Engleman, et al.
Schweizerische Medizinische Wochenschrift
|
March 11, 1989
[Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years]
O Brändli, V Haegi, B Villiger, et al.
Medicine and Science in Sports and Exercise
|
July 11, 2001
Competition performance and basal nocturnal catecholamine excretion in cross-country skiers
B Knöpfli, R Calvert, O Bar-Or, et al.
The American Journal of Cardiology
|
August 15, 1997
Risk for exercise-induced myocardial injury for athletes performing prolonged strenuous endurance exercise
J Mair, W Schobersberger, A Koller, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Schweizerische Medizinische Wochenschrift
|
September 18, 1993
[Effect of inpatient treatment on pulmonary findings and subjective well-being of patients with chronic bronchitis]
S Büchi, C Buddeberg, C Wolf, et al.
The Journal of Biological Chemistry
|
June 10, 1981
Gelatin-binding domain-specific anti-human plasma fibronectin Fab' inhibits fibronectin-mediated gelatin binding but not cell spreading
J A McDonald, T J Broekelmann, D G Kelley, et al.
The American Review of Respiratory Disease
|
November 1, 1981
Bronchoalveolar fibronectin in smokers and nonsmokers
B Villiger, T Broekelmann, D Kelley, et al.
The European Respiratory Journal
|
June 1, 1997
Psychosocial predictors of long-term success of in-patient pulmonary rehabilitation of patients with COPD
S Büchi, B Villiger, T Sensky, et al.
Deutsche Medizinische Wochenschrift (1946)
|
March 20, 1998
[The importance of training intensity for improving endurance capacity of patients with chronic obstructive pulmonary disease]
J D Leuppi, R Zenhäusern, F Schwarz, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|
May 26, 1987
[Combination of anticholinergic, beta-2-sympathomimetic agents and theophylline in the treatment of chronic obstructive lung disease. A double-blind multicenter study of 60 patients]
R Bezel, O Brändli, P Braun, et al.
The Journal of Cell Biology
|
September 1, 1981
Human alveolar macrophage fibronectin: synthesis, secretion, and ultrastructural localization during gelatin-coated latex particle binding
B Villiger, D G Kelley, W Engleman, et al.
Schweizerische Medizinische Wochenschrift
|
March 11, 1989
[Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years]
O Brändli, V Haegi, B Villiger, et al.
Medicine and Science in Sports and Exercise
|
July 11, 2001
Competition performance and basal nocturnal catecholamine excretion in cross-country skiers
B Knöpfli, R Calvert, O Bar-Or, et al.
The American Journal of Cardiology
|
August 15, 1997
Risk for exercise-induced myocardial injury for athletes performing prolonged strenuous endurance exercise
J Mair, W Schobersberger, A Koller, et al.
Page
of 5